Around 70,000 people die each year from infections with the hepatitis E virus. There is currently neither a vaccine nor a specific drug against this virus. This could change with the identification of
The Institute of Infectious Diseases and Tropical Medicine has announced the inclusion of the first study participant in the STEP2C Stage 3 trial. The study is part of the international UNITE4TB
Approximately one in 10,000 people in Germany is affected by primary sclerosing cholangitis (PSC). In order to digest fats from food, the intestine needs bile. This is produced in the liver and from
He is one of the world's leading clinical researchers in the field of tuberculosis (TB): Prof. Dr. Dr. h. c. Christoph Lange has been awarded the DZIF Prize for Translational Infection Research 2025
An international research team has identified a novel HIV antibody that targets the virus at a particularly vulnerable site and overcomes previous limitations of known antibodies. The study, led by
Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and the German Center for Infection Research (DZIF), today announced a strategic research
Phyton Biotech has successfully transferred the manufacturing process for the microbial production of Corallopyronin A (CorA). CorA is a novel anti-infective agent with the potential to address
Urinary tract infections are among the most common reasons for prescribing antibiotics. Since conventional pathogen identification in the laboratory usually takes two to three days, initial treatment
Most malaria drugs are combination therapies based on artemisinin, an active ingredient derived from the medicinal plant Artemisia annua (sweet wormwood). The malaria parasite Plasmodium falciparum is
The World Neglected Tropical Diseases (NTD) Day on January 30 aims to raise awareness of diseases that affect millions of people worldwide but are usually overshadowed by other global health issues
